Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo is a research paper published in Neuro-Oncology Advances (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01NS086219
National Institutes of Health
Grant: T32OD0100993
American Cancer Society
Grant: 123939
National Cancer Institute
Grant: CA77598
NCI NIH HHS
Grant: P30 CA077598
NCI NIH HHS
Grant: UG3 CA244687
NINDS NIH HHS
Grant: R01 NS115438
National Institutes of Health
Grant: 1R01NS086219-01A1
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance
National Institutes of Health
Grant: 5P30CA077598-08
Cancer Center Support Grant P30 CA77598-06
Children's Tumor Foundation
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals